These alterations recapitulate many of the early cerebral vascular changes seen in AD patients, which are not seen in the 5x familial Alzheimer’s disease (FAD) transgenic mouse model, in which the overexpression of APP is targeted to neurons by the Thy1 promoter [12,48,49]. The gene discussed is THY1; the disease is Alzheimer disease.